May 29, 2024 08:04AM
May 29, 2024 08:00AM
May 22, 2024 08:00AM
Apr 16, 2024 08:00AM
Apr 3, 2024 08:02AM
Apr 3, 2024 08:00AM
Feb 14, 2024 05:50AM VBI Vaccines (VBI) to Sell IP Rights for VBI-2601 to Brii Biosciences
Feb 13, 2024 07:04PM
Nov 20, 2023 08:03AM
Nov 20, 2023 08:00AM
Nov 14, 2023 04:05PM
Sep 7, 2023 08:00AM
Aug 14, 2023 08:00AM
Jul 5, 2023 07:18PM Brii Biosciences Provides Latest Clinical Development and Corporate Updates
Apr 4, 2023 08:02AM
Apr 4, 2023 08:00AM
Mar 24, 2023 01:18AM
Mar 13, 2023 08:00AM
Nov 22, 2022 08:03AM
Nov 22, 2022 08:00AM
Aug 8, 2022 08:00AM VBI Vaccines Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Jun 22, 2022 08:01AM
Jun 22, 2022 08:00AM
Jun 6, 2022 08:05AM
Jun 6, 2022 08:00AM
Jun 1, 2022 08:01AM
Jun 1, 2022 08:00AM
May 2, 2022 08:06AM VBI Vaccines (VBIV) Announces European Commission Marketing Authorisation for PreHevbri™, a 3-Antigen Adult Hepatitis B Vaccine
May 2, 2022 08:00AM
Apr 5, 2022 08:04AM
Apr 5, 2022 08:00AM
Mar 29, 2022 08:00AM
Mar 7, 2022 08:00AM
Feb 23, 2022 04:06PM
Feb 23, 2022 04:05PM VBI Vaccines Announces PreHevbrio™ [Hepatitis B Vaccine (Recombinant)] Recommended by CDC Advisory Committee on Immunization Practices for the Prevention of Hepatitis B in Adults
Dec 1, 2021 04:15PM
Dec 1, 2021 09:19AM
Dec 1, 2021 07:31AM
Dec 1, 2021 07:30AM
Nov 8, 2021 08:00AM
Aug 2, 2021 08:00AM
Jul 1, 2021 04:07PM VBI Vaccines (VBIV) Reports New CPT Code Issued for a 3-Antigen Prophylactic Hepatitis B Vaccine
Jul 1, 2021 04:05PM
Jun 8, 2021 08:06AM
Jun 8, 2021 08:00AM
May 10, 2021 08:00AM
Mar 2, 2021 08:00AM
Feb 2, 2021 08:02AM
Feb 2, 2021 08:00AM VBI Vaccines Announces U.S. FDA Acceptance of BLA Filing for VBI’s 3-Antigen Prophylactic Hepatitis B Vaccine
Jan 15, 2021 08:02AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All